Bi-Flow is first bidirectional femoral arterial cannula validated for 29 days’ use LONDON--(BUSINESS WIRE)-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, ...

Please provide your email address to receive an email when new articles are posted on . Odds for survival on ECMO to transplant went down if the patient had an older age at listing. Survival did not ...

Extracorporeal membrane oxygenation (ECMO) is a technique used when both a person’s heart and lungs are in a life-threatening situation. It is an external aid through which the affected person’s blood ...

Please provide your email address to receive an email when new articles are posted on . Among patients receiving extracorporeal membrane oxygenation, the presence of obesity did not impact mortality ...

Extracorporeal membrane oxygenation (ECMO) is a supportive therapy for adults, including during or soon after pregnancy, with severe acute respiratory failure from a potentially reversible cause.

LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow Extracorporeal Membrane Oxygenation (ECMO) cannula earned ...

Bi-Flow is first bidirectional femoral arterial cannula validated for 29 days' use LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow ...